Scheistrøen M - Search Results

1

Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients.

Scheistrøen M, Tropé C, Koern J, Pettersen EO, Abeler VM, Kristensen GB. Scheistrøen M, et al. Cancer. 1995 Jan 1;75(1):72-80. doi: 10.1002/1097-0142(19950101)75:1<72::aid-cncr2820750113>3.0.co;2-g. Cancer. 1995. PMID: 7804980

2

Malignant melanoma of the vulva FIGO stage I: Evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatment.

Scheistrøen M, Tropé C, Kaern J, Abeler VM, Pettersen EO, Kristensen GB. Scheistrøen M, et al. Gynecol Oncol. 1996 May;61(2):253-8. doi: 10.1006/gyno.1996.0135. Gynecol Oncol. 1996. PMID: 8626143

3

DNA ploidy and expression of p53 and C-erbB-2 in extramammary Paget's disease of the vulva.

Scheistrøen M, Tropé C, Kaern J, Pettersen EO, Alfsen GC, Nesland JM. Scheistrøen M, et al. Gynecol Oncol. 1997 Jan;64(1):88-92. doi: 10.1006/gyno.1996.4517. Gynecol Oncol. 1997. PMID: 8995553

4

p53 protein expression in squamous cell carcinoma of the vulva.

Scheistrøen M, Tropé C, Pettersen EO, Nesland JM. Scheistrøen M, et al. Cancer. 1999 Mar 1;85(5):1133-8. doi: 10.1002/(SICI)1097-0142(19990301)85:5<1133::AID-CNCR17>3.0.CO;2-T. Cancer. 1999. PMID: 10091798

5

Have patients with early squamous carcinoma of the vulva been overtreated in the past? The Norwegian experience 1977-1991.

Scheistrøen M, Nesland JM, Tropé C. Scheistrøen M, et al. Eur J Gynaecol Oncol. 2002;23(2):93-103. Eur J Gynaecol Oncol. 2002. PMID: 12013120

6

Cytogenetic characterization of tumors of the vulva and vagina.

Micci F, Teixeira MR, Scheistrøen M, Abeler VM, Heim S. Micci F, et al. Among authors: scheistroen m. Genes Chromosomes Cancer. 2003 Oct;38(2):137-48. doi: 10.1002/gcc.10263. Genes Chromosomes Cancer. 2003. PMID: 12939741

7

Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva.

Scheiströen M, Tropé C. Scheiströen M, et al. Acta Oncol. 1993;32(6):657-61. doi: 10.3109/02841869309092448. Acta Oncol. 1993. PMID: 7505091

8

Surgical management of stage I and II vulvar cancer: the role of the sentinel node biopsy. Review of literature.

Makar AP, Scheistroen M, van den Weyngaert D, Tropé CG. Makar AP, et al. Among authors: scheistroen m. Int J Gynecol Cancer. 2001 Jul-Aug;11(4):255-62. doi: 10.1046/j.1525-1438.2001.011004255.x. Int J Gynecol Cancer. 2001. PMID: 11520362 Review.

9

[Surgery and sentinel node examination in early vulvar cancer].

Tropé C, Scheistrøen M, Aas M, Abeler V, Lie K, Makar A. Tropé C, et al. Among authors: scheistroen m. Tidsskr Nor Laegeforen. 2001 Sep 30;121(23):2723-7. Tidsskr Nor Laegeforen. 2001. PMID: 11699381 Review. Norwegian.

10

First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin.

Kristensen GB, Vergote I, Stuart G, Del Campo JM, Kaern J, Lopez AB, Eisenhauer E, Aavall-Lundquist E, Ridderheim M, Havsteen H, Mirza MR, Scheistroen M, Vrdoljak E. Kristensen GB, et al. Among authors: scheistroen m. Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:172-7. doi: 10.1111/j.1525-1438.2003.13363.x. Int J Gynecol Cancer. 2003. PMID: 14656276 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page